Search

Search Results

• 

  Combination of cyclosporine A and methylprednisolone to treat pediatric Stevens-Johnson syndrome/toxic epidermal necrolysis overlap syndrome

  Shinta Trilaksmi Dewi, Laily Noor Qomariah, Widya Khairunisa Sarkowi, Monika Puspitasari, Miya Khalidah, Marcella Anggatama, Dwinanda Almira Rizkiani, Kristiana Etnawati, Sri Awalia Febriana

  19-06-2023

  https://doi.org/10.4081/dr.2023.9656

  1359

  PDF: 669

  HTML: 199
• 

  Metastatic basal cell carcinoma to the bone: a case of bone metastasis in uncommon sites

  Olga Nigro, Claudio Chini, Ilaria Gioia Angiola Marcon, Annamaria De Giorgi, Linda Bascialla, Elisa Gallerani, Alice Giaquinto, Diego De Palma, Maurizio Lombardo

  12-07-2022

  https://doi.org/10.4081/dr.2022.9267

  1131

  PDF: 534

  Supplementary Table: 253

  HTML: 25

• Lichenoid dermatitis induced by abemaciclib in a patient with HR+/HER2– breast cancer

  Edoardo Mortato, Anna Paola De Caro, Luca Schinzari, Sonia Maniglio, Carmelo Laface, Gerardo Cazzato, Caterina Foti, Francesca Ambrogio

  19-11-2024

  https://doi.org/10.4081/dr.2024.10144

  729

  PDF: 432

  HTML: 47

• A microRNA focus on acne

  Sarah Gordon, Alison M. Layton, Sandra Fawcett, Kehinde Ross

  02-02-2024

  https://doi.org/10.4081/dr.2024.9902

  1165

  PDF: 751

  HTML: 75
• 

  Attitudes among dermatologists regarding actinic keratosis treatment options

  Gaia Moretta, Tonia Samela, Francesca Sampogna, Francesco Ricci, Fabio Carlesimo, Annarita Panebianco, Angelo Massimiliano D’Erme, Giovanni Di Lella, Sabatino Pallotta, Elena Dellambra, Damiano Abeni, Luca Fania

  31-01-2022

  https://doi.org/10.4081/dr.2022.9392

  1147

  PDF: 695

  HTML: 40
• 

  Efficacy of intravenous immunoglobulin monotherapy in patients with cutaneous lupus erythematosus: results of proof-of-concept study

  Christa Ky, Brian Swasdibutra, Shaadi Khademi, Sheetal Desai, Vivian Laquer, Sergei A. Grando

  16-03-2015

  https://doi.org/10.4081/dr.2015.5804

  2841

  PDF: 1170

  HTML: 252
• 

  Delayed immune mediated adverse effects to hyaluronic acid fillers: report of five cases and review of the literature

  Ora Bitterman-Deutsch, Leonid Kogan, Faris Nasser

  30-03-2015

  https://doi.org/10.4081/dr.2015.5851

  4481

  PDF: 1725

  HTML: 1985
• 

  Severe and delayed-onset acneiform eruptions as an adverse reaction to regorafenib

  Haruhiko Otsuka, Takeshi Fukumoto, Naomi Kiyota, Chihiro Takemori, Haruki Jimbo, Chikako Nishigori

  01-01-2022

  https://doi.org/10.4081/dr.2022.9303

  1714

  PDF: 645

  HTML: 22
• 

  Ibrutinib-associated skin toxicity: a case of maculopapular rash in a 79-year old Caucasian male patient with relapsed Waldenstrom’s macroglobulinemia and review of the literature

  Anders Bisgaard Jensen, Birgitte Stausbøl-Grøn, Rikke Riber-Hansen, Francesco d’Amore

  20-04-2017

  https://doi.org/10.4081/dr.2017.6976

  2703

  PDF: 1064

  HTML: 583

• Combination of intravenous immunoglobulin, oral prednisone, and methotrexate for managing scleromyxedema: case report and literature discussion

  Gaia Fasano, Giancarlo Valenti, Domenico D'Amico, Mario Valenti

  24-08-2023

  https://doi.org/10.4081/dr.2023.9803

  984

  PDF: 526

  HTML: 193
• 

  Double hatchet flap as adequate dermatosurgical approach for tumours of the occipital scalp zone: Presentation of two cases

  Georgi Tchernev, Ilia Lozev, Ilia Batashki, Lorraine Joseph Kandathil, Nikhil Oliveira, Jose Carlos Cardoso

  17-03-2022

  https://doi.org/10.4081/dr.2022.9487

  1031

  PDF: 501

  HTML: 165

• 24 | IXEKIZUMAB WITH OR WITHOUT TIRZEPATIDE IN ADULTS WITH PSORIASIS AND OVERWEIGHT OR OBESITY: THE TOGETHER-PSO PHASE 3B RANDOMIZED CLINICAL TRIAL E. Filippi¹, M. Lebwohl², A. Blauvelt³, C. Kartman⁴, C. Leatherwood⁴, K. Gordon⁵, N. Sattar⁶, L. Puig⁷, J. Merola⁸, K. Siu⁴, R. Wang⁴, L. Sun⁴, A. Leung⁹, N. Somani⁴, M. Rueda⁴, A. Cardoso⁴, M. Genovese⁴, A. Armstrong¹⁰, B. Strober¹¹ | ¹Eli Lilly Italy S.p.A, Sesto Fiorentino, Italy; ²Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; ³Blauvelt Consulting, LLC, Annapolis, MD, USA; ⁴Eli Lilly and Company, Indianapolis, IN, USA; ⁵Department of Dermatology, Medical College of Wisconsin, Milwaukee, WI, USA; ⁶School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK; ⁷Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona School of Medicine, Barcelona, Spain; ⁸Department of Dermatology and Department of Medicine, Division of Rheumatology, UT Southwestern Medical Center and O’Donnell School of Public Health, Dallas, TX, USA; ⁹Syneos Health, Morrisville, NC, USA; ¹⁰Division of Dermatology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, CA, USA; ¹¹Department of Dermatology, Yale University School of Medicine, New Haven, CT, Central Connecticut Dermatology Research, Cromwell, CT, USA

  Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica

  24-09-2026

  https://doi.org/10.4081/dr.2026.11086

  119

  PDF: 42

• Review on natural remedies for hair growth promotion with a focus on rosemary

  Atheer G. Almutairi, Fatimah Y. Altheyab, Waseem Alhawsawi, Asem Shadid, Azzam Alkhalifah

  02-02-2026

  https://doi.org/10.4081/dr.2026.10368

  4345

  PDF: 4015
• 

  Vitiligo: What’s old, what’s new

  Mariabeatrice Bertolani, Eleonora Rodighiero, Maria Beatrice de Felici del Giudice, Torello Lotti, Claudio Feliciani, Francesca Satolli

  15-09-2021

  https://doi.org/10.4081/dr.2021.9142

  2922

  PDF: 1198

  HTML: 233

• Psoriasiform eruption induced by dupilumab successfully treated with upadacitinib

  Mattia Minghini, Natale Schettini, Lucrezia Pacetti, Chiara Bocchi, Alessandro Borghi

  16-10-2025

  https://doi.org/10.4081/dr.2025.10588

  462

  PDF: 234

  HTML: 4
• 

  Lenvatinib-induced severe generalized erythematous rash in a patient with hepatocellular carcinoma

  Yukari Matsumoto, Takeshi Fukumoto, Wakako Takahashi, Chikako Nishigori

  29-12-2022

  https://doi.org/10.4081/dr.2023.9617

  887

  PDF: 466

  HTML: 51

• Underrepresentation of atopic dermatitis publications in pediatric journals: a bibliometric analysis

  Barak Zlakishvili, Sarah Weissmann, Amir Horev

  12-04-2024

  https://doi.org/10.4081/dr.2024.9932

  748

  PDF: 557

  SUPPLEMENTARY MATERIAL: 176

  HTML: 21

• Analysis of pediatric outpatient visits uncovers disparities in molluscum contagiosum treatment across medical specialties in the United States

  Karan Rajalingam, Wei-Shen Chen, Ann Lin

  11-10-2023

  https://doi.org/10.4081/dr.2023.9851

  724

  PDF: 454

  HTML: 35
• 

  Certolizumab to treat hidradenitis suppurativa

  Asem Shadid, Saud Alobaida, Yousef Binamer

  27-10-2022

  https://doi.org/10.4081/dr.2022.9566

  1989

  PDF: 758

  HTML: 54

• Acute generalized exanthematous pustulosis triggered by dupilumab

  Caterina Mariarosaria Giorgio, Gaetano Licata, Giuseppe Argenziano, Vittorio Tancredi, Anna Balato, Eugenia Veronica Di Brizzi

  23-07-2025

  https://doi.org/10.4081/dr.2025.10219

  551

  PDF: 359

  HTML: 28
• 

  Erythrodermic psoriasis improved by tildrakizumab

  Giampaolo Trevisan, Lerica Germi, Luigi Naldi

  23-11-2022

  https://doi.org/10.4081/dr.2022.9448

  1374

  PDF: 642

  HTML: 29
• 

  Ethnicity is a major determinant of the pattern of dermatological diseases among pilgrims during the Hajj in 2019

  Futoun Sharaf, Marwa El-Samongy, Nahla Bouqellah, Abdullah Al-Madani, Mohammad Abu-Alruhaylah, Yasir Ashour, Najla Dar-Odeh, Osama Abu-Hammad

  17-03-2021

  https://doi.org/10.4081/dr.2021.8934

  4100

  PDF: 725

  HTML: 18

• 26 | CONCOMITANT THERAPY WITH IXEKIZUMAB PLUS TIRZEPATIDE IN ADULTS WITH PSORIATIC ARTHRITIS AND OVERWEIGHT OR OBESITY DEMONSTRATED SUPERIOR DISEASE CONTROL COMPARED TO IXEKIZUMAB ALONE: RESULTS FROM THE PH3B TOGETHER-PSA TRIAL E. Filippi¹, J. F. Merola², P. Mease³, A. Kivitz⁴, N. Sattar⁵, L. C. Coates⁶, C. E. Kartman⁷, P. Fischer⁷, L. Sun⁷, A. Cardoso⁷, M. C. Genovese⁷, A. Ogdie⁸ | ¹Eli Lilly Italia S.p.A, Florence, Italy; ²Department of Dermatology and Department of Medicine, Division of Rheumatology, UT Southwestern Medical Center and O’Donnell School of Public Health, Dallas, TX, USA; ³Providence Swedish Medical Center, Seattle, WA, USA; ⁴Altoona Center for Clinical Research, Duncansville, PA, USA; ⁵School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK; ⁶Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK; ⁷Eli Lilly and Company, Indianapolis, IN, USA; ⁸Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

  Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica

  24-09-2026

  https://doi.org/10.4081/dr.2026.11088

  111

  PDF: 34

• Efficacy of tildrakizumab 200 mg for treating difficult-to-treat patient populations with moderate-to-severe plaque psoriasis

  Paolo Dapavo, Matteo Megna, Marina Talamonti

  09-08-2024

  https://doi.org/10.4081/dr.2024.9999

  1866

  PDF: 766

  HTML: 109

• Efficacy and safety of topical sofpironium bromide in treating primary axillary hyperhidrosis: systematic review and meta-analysis of randomized controlled trials

  Yuichiro Oshima, Takashi Hashimoto, Hiroshi Miyama, Tomoko Fujimoto

  16-06-2026

  https://doi.org/10.4081/dr.2026.10853

  1064

  PDF: 405